Skip to main navigation Skip to search Skip to main content

Overcoming hERG issues for brain-penetrating cathepsin S inhibitors: 2-Cyanopyrimidines. Part 2

  • Osamu Irie*
  • , Takatoshi Kosaka
  • , Masashi Kishida
  • , Junichi Sakaki
  • , Keiichi Masuya
  • , Kazuhide Konishi
  • , Fumiaki Yokokawa
  • , Takeru Ehara
  • , Atsuko Iwasaki
  • , Yuki Iwaki
  • , Yuko Hitomi
  • , Atsushi Toyao
  • , Hiroki Gunji
  • , Naoki Teno
  • , Genji Iwasaki
  • , Hajime Hirao
  • , Takanori Kanazawa
  • , Keiko Tanabe
  • , Peter C. Hiestand
  • , Marzia Malcangio
    • Alyson J. Fox, Stuart J. Bevan, Mohammed Yaqoob, Andrew J. Culshaw, Terance W. Hart, Allan Hallett
*Corresponding author for this work

Research output: Journal Publications and Reviews › RGC 21 - Publication in refereed journal › peer-review

27   Link opens in a new tab Citations (Scopus)

Fingerprint

Dive into the research topics of 'Overcoming hERG issues for brain-penetrating cathepsin S inhibitors: 2-Cyanopyrimidines. Part 2'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science